Flutamide, which has antiandrogenic properties, was administered to pregnant rats, and effects on male offspring were examined. Crj : CD (SD) IGS (SPF) females were administered flutamide (0.15, 0.6, 2.5, 10.0, 100 mg/kg, P.O.) from gestation Day 14 to post parturition Day 3. The number of pups, body weights, clinical features, anogenital distance (AGD), nipple retention, testicular descent, and urogenital malformation in F1 males were examined. Hormone measurement, necropsy and histopathological examination were carried out at post-neonatal Day 4 (PND 4) and PND 60. Sperm analysis was also carried out at PND 60. Decrease in body weight was seen in the 100 mg/kg group and the AGD was decreased at 2.5 mg/kg and above. Retention of nipples, hypospadia, vaginal pouches, penis malformation, unilateral ectopic testis, and decrease of organ weights (prostate, seminal vesicles, levator ani muscle plus bulbocavernosus muscle, testis) were observed at 10 mg/kg and above. Testicular testosterone (T) was increased significantly with 100 mg/kg at PND 4 and tendencies for increase were observed in serum T, LH and FSH at 10 mg/kg and more at the same time point. In contrast, elevated levels of LH and FSH were seen with 100 mg/kg at PND 60. Histopathological examination revealed defects or hypoplastic changes of genital organs (≥10 mg/kg), squamous metaplasia (10 mg/kg) or mucification (100 mg/kg) of the urethral diverticulum epithelium and inflammation of genital organs (100 mg/kg). Though only undescended testes lacked spermatogenesis at 10 mg/kg, atrophic change of seminiferous tubules and azoospermia were observed in the 100 mg/kg group, despite testicular descent. Perinatal administration of flutamide affected F1 male rats at 2.5 mg/kg and above. In addition to urogenital malformation, 100 mg/kg flutamide caused high LH and FSH levels at PND 60. This study indicates that the most sensitive parameter is AGD, whereby reduction was observed at 2.5 mg/kg. A clear no-effect level (NOEL: 0.6 mg/kg) was obtained in this perinatal study of an antiandrogenic chemical.
INTRODUCTION
Exposure to some synthetic or naturally existent chemicals that induce hormonal imbalance can produce reproductive abnormalities in humans and wildlife. Recently, many trials have been carried out to establish screening assays and generate data for chemicals that have estrogenic, anti-androgenic or other hormonal activity.
Male sexual differentiation and reproductive development are androgen-dependent. Therefore, androgen deficiency caused by exposure to antiandrogens during critical development stages results in various sexual aberrations in male animals; decrease in AGD, increase in nipple retention, undevelopment or absent reproductive organs, malformed external genitalia (hypospadia), undescended testis (cryptorchidism), cleft phallus and a blind vaginal pouch, and decreased sperm production (Mylchreest et al., 1998; Gray et al., 1994; You et al., 1998; Ostby et al., 1999) . The androgens, testosterone (T) and 5alphadihydrotestosterone (DHT), produced by the fetal/ neonatal male during sexual differentiation are critical determinants of the male phenotype (Wilson, 1978) . Wolf showed the most sensitive period is GD16-17, during the fetal period (GD12-21), with exposure to vinclozolin, a fungicide having an antiandrogenic character (Wolf et al., 2000) .
Flutamide, a nonsteroidal antiandrogen drug used in the treatment of prostatic cancer, is well known as a potent androgen receptor (AR) antagonist. This drug has been used as a positive control in many Hershberger assays, male pubertal assays, and enhanced OECD 407 28-day studies, which are recommended for screening endocrine-disrupting chemicals by EPA and/or OECD (Yamada et al., 2000; Toyoda et al., 2000) . Though Hershberger and male pubertal assays are very sensitive for detecting any potential to disrupt hormone function through androgen receptor binding, results obtained from reproductive/generation studies are thought to be particularly important for decisions as to endocrine disrupting chemicals (EDCs). Because the most severe effects are induced with exposure in a critical period, this was chosen here for an abbreviated and convenient alternative to standard reproductive studies. We thus administered flutamide to pregnant rats from Gestational Day 14 to Postnatal Day 3, the period of sex differentiation in the rat . Many authors have applied this administration period to identify EDCs Parks et al., 2000; .
There have been a number of studies concerning low-dose exposure to EDCs since the low dose of bisphenol A effects were reported by Nagel et al. (1997) . Some studies, including those conducted by vom Saal's group, revealed the low-dose effects (Nagel et al., 1997; vom Saal et al., 1998; Howdeshell et al., 1999; Gupta, 2000; Atanassova et al., 1999) , while others did not (Cagen et al., 1999a (Cagen et al., , 1999b Ashby et al., 1999; Elswick et al., 2000; Tyl et al., 1999) . A review panel concerning low-dose effects, organized by the National Toxicology Program, was held in October 10-12, 2000 and concluded in a report released August, 2001 (NTP, 2001 ) that there was "credible evidence" that some hormone-like chemicals can affect test animals' bodily functions at very low levels -well below the "no effect" levels determined by traditional testing. Furthermore, the panel reported that, in some cases, credible studies had failed to observe any such low-dose effects without any obvious reason for the different outcomes. Almost all of the review data were related to estrogenic compounds. Regarding antiandrogenic compounds, only a few findings are available, and they reviewed vinclozolin data not conducted in dose-ranges below NOAEL/ LOAEL. In this vinclozolin review, the panel noted the AGD of F1 male to be the most sensitive endpoint, and the dose-response curve displayed no threshold and appeared linear to the lowest test dose.
Our objectives were to obtain a no-effect level (NOEL) for flutamide and basic dose-related data, including findings for histopathological abnormalities, and to identify the most sensitive parameter among the items that are routinely examined in reproductive studies. Furthermore, we compared results for the most sensitive parameter in the present study with findings from Hershberger and male pubertal assays to ascertain comparative sensitivities and clarify differences in dose-dependence. For that purpose, we chose the same doses of flutamide that were used earlier (Yamada et al., 2000) , and one higher dose (100 mg/kg).
MATERIALS AND METHODS

Animals and treatment
30 Crj :CD (SD) IGS (SPF) female rats at gestation Day 10 were purchased from Charles River Japan Inc. (Gestation Day 0 means the day sperm were detected in vaginal smears.) They were individually housed in polycarbonate cages (W260×L412×H195 mm) with cellulose fiber chips under controlled environmental conditions, including a temperature of 20-24°C, a relative humidity of 53-60%, a frequency of ventilation of more than 15 air exchanges/hr, and a 12-hr light/12-hr dark cycle. Animals were provided NMF diet (Oriental Yeast, Co. Ltd., Japan) through the pregnancy and lactation periods, and MF (Oriental Yeast, Co. Ltd., Japan) after weaning. Drinking water and pellet rodent diet were available ad libitum.
Dams were administered flutamide (Sigma Chemical Co. Ltd., USA) in 0.5% carboxymethylcellulose by gavage at 0.15, 0.6, 2.5, 10.0, 100 mg/ kg/day from gestation Day 14 (GD 14) to postparturition day 3 (PPD 3) . The dams were allocated to groups as follows: 5 animals for Control and 0.15 mg/ kg, 6 animals for 0.6 and 2.5 mg/kg, 4 animals for 10.0 and 100 mg/kg. Controls received the vehicle only (5 ml/kg/day). Dam body weights were measured from GD 10 to PPD 21, every 2 or 3 days during gestation and weekly during lactation, and clinical signs were recorded daily.
Following delivery of entire litters (PND 0), the numbers of live pups and the proportions of males/ females were counted, and clinical signs and mortality were recorded. Pups were killed at PND 4, leaving 8 pups (including 3 to 5 males) per dam. AGD was measured with electronic calipers (0.03-mm accuracy, Japan Micrometer Mfg ) at PND 0, 21, 60. Retention of nipples was examined at PND 12 and 60. Pups' body weights were measured weekly and they were examined for clinical signs daily. Dams and surplus pups were killed after weaning (PND21) under ether anesthesia. The remaining male pups (2 pups/dam for controls, 0.15, 0.6 and 2.5 mg/kg, 2 or 3 pups/dam for 10.0 and 100 mg/kg) were sacrificed at PND 60.
Hormone assay
Male pups were euthanized by blood withdrawal from the abdominal aorta under light CO 2 anesthesia at PND 4 or light ether anesthesia at PND 60. Serum was prepared from a portion of the collected blood and was stored with dissected unilateral testes at PND 4 and descended unilateral testes at PND 60 at -80°C until analysis of hormone concentrations.
Serum of 6-11 pups in the same group at PND 4 was pooled as one sample. One ml of pooled serum was vortexed with 3.0 ml diethyl ether twice. The ether extract was collected and allowed to evaporate completely and the residue was reconstituted with zero calibrator A supplied with the DPC total Testosterone kit described below, and used as a sample for the determination of pooled serum T. For the determination of testicular T, thawed testes were weighted and homogenized in 0.5 ml (PND 4) or 10 ml (PND 60) distilled water. After centrifugation at 3000 rpm for 10 min at 4°C the supernatant fraction was used as a sample to determine testicular testosterone. Pooled serum T, LH and FSH for pups at PND 4 and PND 60, and testicular T of pups were measured with the following commercially available RIA kits: DPC total Testosterone kit (Diagnostic Products Corporation, Los Angeles, U.S.A); Rat lutenizing hormone (rLH)[I 125 ] assay system (Amersham Pharmacia, Biotech Ltd., Buckinghamshire, U.K.); and Rat follicle stimulating hormone (rFSH)[I 125 ] assay system (Amersham Pharmacia, Biotech Ltd., Buckinghamshire, U.K.).
Necropsy and organ weight
Surplus pups were killed at PND 4 and necropsy of males was conducted under a stereoscopic microscope. Abnormalities were recorded and testes with epididymes and accessory organs (seminal vesicles and prostate with urinary bladder) were carefully removed .
With male pups killed at PND 60 for necropsy, the following organs were removed and weighed: testes; prostate (ventral, dorso-lateral); epididymes; seminal vesicles with coagulating glands; and levator ani plus bulbocavernosus muscles (L-B muscle). The paired organs (testes and epididymes) were weighed together.
Histopathological examination
Following necropsy, organs removed at PND 4 and 60 were fixed in 10% neutral buffered formalin or 4% paraformaldehyde solution, excluding testes at PND 60 (Bouin's solution). Routinely prepared paraffin embedded sections were stained with haematoxylin and eosin for light microscopic examination.
Immunohistochemical staining for androgen receptors was carried out with testis, prostate, seminal vesicle and L-B muscle sections. They were incubated with a specific antibody: AR N-20 (Cat. No. sc-816, Santa Cruz Biotechnology Inc. California) overnight at 4°C(1:500 diluted with phosphate-buffered saline) followed by the ABC method. Peroxidase activity was detected using diaminobenzidine. For nuclear staining, haematoxylin was used.
With spermatogenesis estimation, stage analysis was conducted for testicular seminiferous tubules at PND 60. This stage analysis could not be carried out for 100 mg/kg testes because of severe aspermatogenesis.
Sperm analysis
Sperm analysis was conducted at PND 60. For sperm motility, the right cauda epididymis was cut with the tip of a pair of surgical scissors and a small amount of the sperm fluid which leaked out was collected using a glass rod and introduced into medium (M199, Invitrogen Corp., USA) to diffuse the sperm at 37°C. After 5 min, microscopic examination was performed. The right testes frozen for storage until sperm head counting were thawed and homogenization-resistant sperm heads were counted. If the right side organs showed ectopia, the examination was repeated for the left side.
Statistical analysis
Data were tested by Bartlett's test (Bartlett, 1937 ) for homogeneity of variance. When significant treatment differences (p<0.05) were indicated, the Dunnet Multiple Comparison Test (Dunnet, 1964 ) was used to compare each treatment group with the control group. Where heterogeneity of variance was evident from Bartlett's test, the Steel Multiple Comparison Test (Steel, 1959) was used. Significant differences from the control group were estimated at probability levels of 1 and 5%.
RESULTS
Dams
No effects of flutamide exposure on dams were observed except a slightly lower body weight gain from GD 18 to GD21 at 100 mg/kg. All dams delivered at GD 21 or 22. The number of pups and proportions of males/females did not differ from the control group (data were not shown).
Body weight and abnormalities
Body weights in the 100 mg/kg group were reduced as compared to controls from PND 0 to PND 60 ( Fig. 1 ). Decrease of AGD was observed at 2.5 mg/ kg and above (Table 1) . At PND 0, a significant decrease of AGD was found for 10 mg/kg. The 100 mg/kg male pups could not be distinguished from females, and no data could be generated. AGD was significantly decreased at 2.5 mg/kg and more at PND 21, and 10 mg/kg and more at PND 60, with a tendency for reduction also evident with 2.5 mg/kg at PND 60. Retention of nipples was observed with 10 mg/kg at PND 12, and 100 mg/kg at PND 12 and 60 (Table 2) .
At necropsy on PND 4, prostates and seminal vesicles could not be confirmed with 100 mg/kg, and were only rudimentary under the stereoscopic microscope (data not shown). At PND 60, hypospadias, vaginal pouches, penis malformation, ectopic testis, and reduction in size of testes, epididymides, L-B muscles, prostates and seminal vesicles were seen at 10 mg/kg and above. All ectopic testes were unilateral. At 100 mg/kg, neither ventral nor dorso-lateral prostates could be recognized at necropsy in almost all animals, and L-B muscle and seminal vesicles were apparently lacking in a few animals ( Table 2) .
Relative organ weights (per body weight) of prostate and L-B muscle were significantly decreased at 10 mg/kg and above as well as for seminal vesicles at 100 mg/kg, and showed a tendency for decrease with testes at 10 mg/kg and above (Table 3) .
Hormone assay
At PND 4, pooled serum of 6-11 rats demonstrated tendencies for increase in serum T, LH and FSH at 10 mg/kg and above. The mean values for serum T, LH and FSH were 0.83 ± 0.17 ng/ml, 2.8 ± 1.06 ng/ml, 14.6 ± 3.75 ng/ml at 10 mg/kg, 0.85 ng/ ml, 4.3 ng/ml, 16.3 ng/ml at 100 mg/kg, in comparison with 0.43 ± 0.148 ng/ml, 1.2 ± 0.28 ng/ml, 8.5 ± 0.49 ng/ml, respectively, for the Controls. Testicular T at 100 mg/kg (1197 ± 565.9 ng/g) was significantly higher than the Control value (465 ± 300 ng/g) In contrast, at PND 60, LH (2.3 ± 0.42 ng/ml) and FSH (13.5 ± 2.37 ng/ml) levels with 100 mg/kg were elevated as compared to the Controls (1.9 ± 0.30 ng/ml, 8.5 ± 0.37 ng/ml, respectively). Although significant elevation of FSH was observed at 2.5 mg/kg FSH (10.8 ± 2.27 ng/ml), this was considered accidental, because there was no dose-dependence (Table 4) .
Histopathological examination
At PND 60, histopathological examination also revealed hypoplastic changes of genital organs at 10 mg/kg and above (Table 5 ). Atrophic seminiferous tubules (decreased spermatogenesis) were observed in ectopic testes at 10 mg/kg. On the other hand, microscopic examination including stage analysis revealed no failure in spermatogenesis in the descending testis at 10 mg/kg. At 100 mg/kg, almost complete failure of spermatogenesis was evident despite testicular descent. The atrophic tubules included Sertoli cells 
Values are means SD (n). ** : Significantly different from the Control value, p < 0.01. N/A: No available data because of difficulty of sex distinction. Relative organ weights (%) for 60-day-old male offspring exposed perinatally to flutamide. 
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(2) Hormone assay results for male offspring exposed perinatally to flutamide. Table 4 .
only or with a few spermatocytes and staining with AR immuno-histochemistry was weak, in clear contrast to the intense staining of stage I-VI tubules in controls (Photo 1). Leydig cells were not different from Controls on H/E staining or AR immuno-staining. Hypoplasia, presence of spermatocytes and spermatids, and hypospermia and azoospermia were observed in epididymides at 100 mg/kg and inflammatory cells or lymphoid cell infiltration were noted in seminal vesicles and L-B muscles at 10 mg/kg and above (Photo 2). Furthermore, squamous metaplasia (10 mg/kg) or mucification (100 mg/kg) of urethral diverticulum epithelium surrounded by bulbocavernosus muscles were recognized (Photo 3). There were no compoundrelated changes in testes on H/E staining and AR immuno-reactions at PND 4 and in AR immuno-reactions in prostates, seminal vesicles and epididymides at PND 4 and 60.
Sperm analysis
There were no differences in sperm counts or motility at 2.5 mg/kg or less, or for descending testes/ epididymes at 10 mg/kg (Fig. 2) . At 100 mg/kg, descended testes produced few sperm, and active sperm were not observed in any cauda epididymis (data not shown).
DISCUSSION
In the present study, flutamide caused a tendency for decrease in body weight gain from GD 18 to GD 21 in dams at 100 mg/kg, but no other effects of exposure were observed regarding the dams, the numbers of pups and proportions of males/females. The dam body weight decrease may have been responsible for the body weight decrease for pups of the 100 mg/kg group from PND 0 to PND 60. No clinical signs were noticed for pups, and there were no differences in relative liver and kidney organ weights from Control values (data not shown).
However, flutamide given to rats from GD 14 to PND 3 caused abnormalities of androgen-dependent organs in male offspring. For example, decrease of AGD was observed at 2.5 mg/kg and above and Table 5 . Incidences of microscopic findings in 60-day-old male offspring exposed perinatally to flutamide (%).
Findings
Control 0.15 0.6 2.5 10 100 (mg/kg) (10) (10) (12) (12) (10) retention of nipples, ectopic testis, hypospadias, vaginal pouches and penis malformation were seen from 10 mg/kg, along with reduction in relative weights of prostate and L-B muscle. With seminal vesicles relative organ weights were decreased at 100 mg/kg, and a similar tendency was observed, also encompassing the testes, at 10 mg/kg. Similar effects of antiandrogenic compounds on male rats have been demonstrated in many studies with perinatal administration (Imperato-McGinley et al., 1992; van der Schoot, 1992; Kassim et al., 1997; Kelce et al., 1994 Kelce et al., , 1995 Gray et al.,1994; You et al., 1998 ) .
There have been several reports and reviews regarding the mechanisms underlying endocrine disruptor effects (Creasy, 1999; Kelce et al.,1997) . It has been reported that flutamide blocks the physiolog-ical action of testosterone at androgenic receptor sites, altering steady-state levels of specific androgen receptor-regulated gene expression in vivo. Therefore, it can be speculated that flutamide causes atrophic changes of seminiferous tubules through depressing the functions of Sertoli cells, with higher levels of serum LH due to disturbance of the negative feedback loop between the pituitary and the testis. Diffuse hyperplasia of Leydig cells has been described following treatment with perinatal flutamide at 100 mg/kg from GD 12 to 21 (Mylchreest et al., 1999) . Mylchreest et al. also reported focal hyperplasia or interstitial cell adenoma in di(n-butyl) phthalate treated animals. They conducted postmortem examination at PND 100-105. In the present study, we could not find any Leydig cell abnormalities, histopathologically, at PND 60.The Photo 1. Immunohistochemical findings for AR at PND 60. a) Control, b) 100 mg/kg.
Control Sertoli cells show stage-specific staining, while those of 100 mg/kg have only weak staining (×220). apparent anomaly might be related to differences in age. Leydig cell hyperplastic legion may have occurred at later ages. In this study, pooled serum samples demonstrated tendencies for increase in serum T, LH, FSH and testicular T at 10 mg/kg and above at PND 4. However, weights of reproductive organs were decreased at 10 mg/kg and above. It can be speculated that flutamide blocks the hormonal activity at the receptor cite of these organs. Decrease of AGD was observed at 2.5 mg/kg, where the hormonal changes were not evident, so this appears to be the most sensitive parameter. Changes of serum hormones do not necessarily accompany the antiandrogenic effect such as the decrease of AGD and reproductive organ weight.
At 10 mg/kg which caused urogenital malformations, the tendency for increased serum LH evident at PND 4 had disappeared at PND 60. These data suggest that the hormone imbalance induced by perinatal flutamide administration might be reversible at 10 mg/ kg. At PND 60, and no effects on serum T were evident. On the other hand, increases in LH and FSH were recognized, again pointing to effects on the feedback system in the hypothalamus. You et al. (1998) observed a decrease in AR immunoreactivity and increase in AR mRNA in the testis at PND 21 after exposure to p,p'-DDE or flutamide prenatally (GD 14-PND 18). According to their report, the number of Sertoli cells showing positive staining in the p,p'-DDE 100 mg/kg-treated group was less than in the controls, while in the flutamide-treated group there was no overt change in the number of AR-positive cells but a general reduction of AR staining intensity in the Sertoli, peritubular, and interstitial cells. In the present study, only Sertoli cells in the atrophic tubules showed weak staining with AR immuno-histochemistry at PND 60. On the other hand, Sertoli cells of the control group Photo 2. Histological appearance of seminal vesicles of 100 mg/kg at PND 60.
Note inflammatory and lymphoid cell infiltration (×120). Vol. 27 No. 1 revealed intense staining in stage I-VI tubules, consistent with an earlier report (Bremner et al., 1994) . We conclude that Sertoli cells did not show stagespecific AR changes in the treated group and there was no compound-related alteration in immunoreactivity of AR either in testes at PND 4 or in prostates, seminal vesicles and L-B muscles at PND 4 and 60. The reasons for the differences in results obtained between our study and the experiment of You et al. (1998) , in spite of the similar experimental protocol await future clarification. Non-descent of testes commonly occurred unilaterally with 10 mg/kg and 100 mg/kg flutamide in the present study, as reported previously, though the reason was not clear (van der Schoot, 1992) . The descended testes of 10 mg/kg group F1 males were morphologically normal, while those of 100 mg/kg F1 do not show any spermatogenesis despite normal T levels in the serum and testis. At 10 mg/kg, the effect on spermatogenesis may have occurred only with failure of testicular descent, since atrophic changes are related to the high temperature in the ectopic scrota . On the other hand, 100 mg/kg flutamide appears to exert direct actions on Sertoli cells and/or spermatogonia.
Histopathological examination revealed squamous metaplasia (10 mg/kg) or mucification (100 mg/ kg) of urethral diverticulum epithelium that consists of transitional epithelial cells. Urethral diverticulum, surrounded by the bulbocavernous muscle, narrows and extends to the pars penis urethra. The histopathological characteristics of urethral diverticulum epithelium partly resemble those of vaginal epithelium. Therefore, the epithelial changes of urethral diverticulum might Photo 3. Histological sections of urethral diverticulum at PND 60. a) Control, b) 10 mg/kg, c) 100 mg/kg. The Control epithelium is transitional. Note the squamous epithelium at 10 mg/kg and the mucinous epithelium at 100 mg/kg (×110). be related to vaginal pouch formation at 10 and 100 mg/kg. Inflammatory or lymphoid cell infiltration was observed in seminal vesicles and L-B muscles in our 10 mg/kg and 100 mg/kg groups. IgA and its secretory component in organs of the male reproductive tract are influenced by DHT and estrogen (Stern et al., 1992) . Antiandrogens such as flutamide and p,p'-DDE, as well as estrogen can cause prostatitis (Seethalakshmi et al., 1996; You et al., 1999; Stoker et al., 1999 ) . The prostates showed neutrophil and macrophage infiltration in the lumen in PND 80 animals after utero exposure to p,p'-DDE or flutamide from GD 12 to 18 (You et al., 1999) . Those changes could have been linked to hormone imbalance, and might be attributable to urethritis related to the formation of hypospadia.
In the present study, we administered the chemical from GD 14 to PND 3, because the most important or severe effects would be expected to be induced by exposure in this critical period of sex differentiation of the rat. Hershberber and male pubertal assays have been recommended as reliable screening methods to detect endocrine-disrupting compounds (EDSTAC, 1998; EPA EDSP, 1998) . A Hershberger assay of flutamide using about the same doses was carried out in our laboratory and revealed decreased organ weights at 0.6 mg/kg/day for 5 days (Yamada et al., 2000) . In addition, a 20-day pubertal male assay in our laboratory revealed a decrease in the number of spermatogenic cells at 0.6 mg/kg (Okuno and Miyata, 2001) . On the other hand, the present study showed a decrease of AGD at 2.5 mg/kg. Thus the Hershberger assay and 20-day pubertal male assay appear more sensitive. In-utero and/or perinatal lowdose exposure, however, does not necessarily cause severe effects, and in a peer review meeting organized by the National Toxicology Program in North Carolina in October 2000, it was discussed whether low doses of some chemicals can indeed cause endocrine effects in laboratory animals. The androgen/anti-androgens subpanel concluded that there is currently no evidence for low-dose anti-androgenic effects (NTP, 2001; EE letter, 2000) . The present data provide support for this conclusion with a clear NOEL (0.6 mg/kg). Fig. 2 . Sperm analysis of male offspring exposed perinatally to flutamide. a: sperm mortility in cauda epididymis, b: sperm count in unilateral testis. Descending testes/epididymides at 10 mg/kg were not affected.
Comparative evaluation of a 5-day Hershberger Assay utilizing mature male rats and a 20-day assay utilizing immature intact male rats for detection of flutamide's antiandrogenic activity. Toxicol. Sci., 53, 289-296. You, L., Casanova M., Archibeque-Engle, S., Sar, M., Fan, L. and Heck, H.d'A. (1998) : Impaired male sexual development in perinatal Sprague-Dawley and Long-Evans hooded rats exposed in utero and lactationally to p,p '-DDE. Toxicol. Sci., 45, 162-173. You, L., Brenneman, K.A. and Heck, H.d'A. (1999) : In utero exposure to antiandrogens alters the responsiveness of the prostate to p,p'-DDE in adult rats and may induce prostatic inflammation. Toxicol. Appl. Pharmacol., 161, 258-266.
